The mechanisms by which oncolytic vaccinia virus induces tumor cell death are poorly understood. We have evaluated cell death pathways following infection of ovarian cancer cells with both wild-type and thy-midine kinase-deleted (dTK) Lister strain vaccinia. We show that death does not rely upon classical apoptosis despite the appearances of some limited apoptotic fea-tures, including phosphatidylserine externalization and appearance of sub-G1 DNA populations. Vaccinia infec-tion induces marked lipidation of LC3 proteins, but there is no general activation of the autophagic process and cell death does not rely upon autophagy induc-tion. We show that vaccinia induces necrotic morphol-ogy on transmission electron microscopy, accompanied by ma...
Oncolytic viruses (OVs) are novel immunotherapeutic agents whose anticancer effects come from both o...
Our previous studies demonstrated that arming vaccinia viruses with marine lectins enhanced the anti...
Oncolytic viruses (OVs) are novel immunotherapeutic agents whose anticancer effects come from both o...
The mechanisms by which oncolytic vaccinia virus induces tumor cell death are poorly understood. We ...
The mechanisms by which oncolytic vaccinia virus induces tumour cell death are poorly understood. We...
Regulated cell death is a powerful anti-viral mechanism capable of aborting the virus replicative cy...
Oncolytic viruses have the potential to induce immunogenic cell death (ICD) that may provoke potent ...
abstract: With the advent of precision medicine, oncologists aim to target tumors that do not respon...
abstract: Since the molecular biology revolution in the 1980s, ease of gene editing had led to the r...
Oncolytic viruses (OVs) are selected or designed to eliminate malignancies by direct infection and l...
Vaccinia virus (VV) infects a broad range of host cells, and while it usually causes their lysis (i....
Vaccinia virus (VACV) was formerly used in the eradication campaign against smallpox. VACV infection...
Vaccinia virus is one of several live viruses currently being evaluated in clinical trials as cancer...
We have demonstrated that oncolytic vaccinia virus synergizes with doxorubicin (DOX) in inducing imm...
Apoptosis and necrosis are the two major cell death pathways. Recently a new cell death pathway was ...
Oncolytic viruses (OVs) are novel immunotherapeutic agents whose anticancer effects come from both o...
Our previous studies demonstrated that arming vaccinia viruses with marine lectins enhanced the anti...
Oncolytic viruses (OVs) are novel immunotherapeutic agents whose anticancer effects come from both o...
The mechanisms by which oncolytic vaccinia virus induces tumor cell death are poorly understood. We ...
The mechanisms by which oncolytic vaccinia virus induces tumour cell death are poorly understood. We...
Regulated cell death is a powerful anti-viral mechanism capable of aborting the virus replicative cy...
Oncolytic viruses have the potential to induce immunogenic cell death (ICD) that may provoke potent ...
abstract: With the advent of precision medicine, oncologists aim to target tumors that do not respon...
abstract: Since the molecular biology revolution in the 1980s, ease of gene editing had led to the r...
Oncolytic viruses (OVs) are selected or designed to eliminate malignancies by direct infection and l...
Vaccinia virus (VV) infects a broad range of host cells, and while it usually causes their lysis (i....
Vaccinia virus (VACV) was formerly used in the eradication campaign against smallpox. VACV infection...
Vaccinia virus is one of several live viruses currently being evaluated in clinical trials as cancer...
We have demonstrated that oncolytic vaccinia virus synergizes with doxorubicin (DOX) in inducing imm...
Apoptosis and necrosis are the two major cell death pathways. Recently a new cell death pathway was ...
Oncolytic viruses (OVs) are novel immunotherapeutic agents whose anticancer effects come from both o...
Our previous studies demonstrated that arming vaccinia viruses with marine lectins enhanced the anti...
Oncolytic viruses (OVs) are novel immunotherapeutic agents whose anticancer effects come from both o...